IRISanRaf

BARBANTI, PIERO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.762
AS - Asia 2.369
EU - Europa 631
SA - Sud America 393
Continente sconosciuto - Info sul continente non disponibili 67
AF - Africa 55
OC - Oceania 13
Totale 7.290
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.293
TR - Turchia 1.052
CN - Cina 486
SG - Singapore 472
CA - Canada 445
BR - Brasile 314
IT - Italia 170
VN - Vietnam 138
IE - Irlanda 71
UA - Ucraina 71
EU - Europa 65
DE - Germania 64
IN - India 64
GB - Regno Unito 55
RU - Federazione Russa 53
FI - Finlandia 35
HK - Hong Kong 33
AR - Argentina 29
ES - Italia 21
ID - Indonesia 21
NL - Olanda 21
MX - Messico 17
EC - Ecuador 16
SC - Seychelles 16
BD - Bangladesh 15
JP - Giappone 15
PK - Pakistan 13
ZA - Sudafrica 13
FR - Francia 11
SE - Svezia 11
AU - Australia 10
CO - Colombia 8
EG - Egitto 8
PL - Polonia 8
PY - Paraguay 7
VE - Venezuela 7
CL - Cile 6
IL - Israele 6
KE - Kenya 6
RO - Romania 6
IQ - Iraq 5
IR - Iran 5
KR - Corea 5
SA - Arabia Saudita 5
TW - Taiwan 5
CZ - Repubblica Ceca 4
DK - Danimarca 4
KZ - Kazakistan 4
MA - Marocco 4
PH - Filippine 4
PT - Portogallo 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
CH - Svizzera 3
NO - Norvegia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
TN - Tunisia 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AF - Afghanistan, Repubblica islamica di 2
AZ - Azerbaigian 2
BW - Botswana 2
DZ - Algeria 2
HN - Honduras 2
HR - Croazia 2
LT - Lituania 2
MN - Mongolia 2
MT - Malta 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
GF - Guiana Francese 1
GP - Guadalupe 1
GY - Guiana 1
KH - Cambogia 1
LB - Libano 1
MY - Malesia 1
NA - Namibia 1
NI - Nicaragua 1
OM - Oman 1
PE - Perù 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 7.290
Salva come PNG Salva come JPEG
Città #
Kocaeli 926
San Mateo 664
Dallas 622
Toronto 421
Wilmington 223
Santa Clara 190
Houston 181
Singapore 169
Lawrence 140
Princeton 140
Ashburn 139
Beijing 129
Fairfield 74
Los Angeles 60
Ho Chi Minh City 57
Seattle 54
Chandler 49
West Jordan 46
Redwood City 43
São Paulo 40
Shanghai 38
Woodbridge 34
New York 32
Hanoi 31
Hong Kong 31
Rome 30
Brooklyn 29
Guangzhou 26
Helsinki 25
Cambridge 24
Dublin 24
Frankfurt am Main 22
Milan 16
Shenzhen 13
Vicenza 13
London 11
Munich 11
Tokyo 11
Chicago 10
Rio de Janeiro 10
Suffern 10
Atlanta 9
Council Bluffs 9
Montreal 9
Boston 8
Denver 8
Haiphong 8
Mexico City 8
Saint Petersburg 8
San Francisco 8
Andover 7
Charlotte 7
Johannesburg 7
Quito 7
Rui'an 7
Secaucus 7
The Dalles 7
Turku 7
Wuhan 7
Ankara 6
Curitiba 6
Islamabad 6
Nairobi 6
Philadelphia 6
Phoenix 6
St Petersburg 6
Warsaw 6
Washington 6
Wuxi 6
Amsterdam 5
Ann Arbor 5
Belo Horizonte 5
Borås 5
Jiaxing 5
Kansas City 5
Miami 5
Pune 5
Quanzhou 5
Xi'an 5
Almaty 4
Biên Hòa 4
Buenos Aires 4
Buffalo 4
Chennai 4
Columbus 4
Da Nang 4
Dhaka 4
Durban 4
Florence 4
Fontebuona 4
Guayaquil 4
Ha Long 4
Karachi 4
Kyiv 4
Manchester 4
Medellín 4
Nanjing 4
Nantong 4
Pelotas 4
Pittsburgh 4
Totale 5.150
Salva come PNG Salva come JPEG
Nome #
A 24-week prospective, multicenter, real-world study on eptinezumab’s effectiveness and safety in migraine prevention (EMBRACE II) 304
Rationale for use of onabotulinum toxin A (BOTOX) in chronic migraine 121
A Systems Medicine Clinical Platform for Understanding and Managing Non-Communicable Diseases 112
Donepezil in the treatment of hallucinations and delusions in Parkinson's disease 99
A case-control study on excessive daytime sleepiness in chronic migraine 87
A case - control study on excessive daytime sleepiness in episodic migraine 84
Amitriptyline in preventive treatment of tension headaches in non-depressed patients is efficient for chronic, but not for episodic cases 84
A case-control study on excessive daytime sleepiness in chronic migraine 82
Look beyond Catechol-O-Methyltransferase genotype for cathecolamines derangement in migraine: the BioBIM rs4818 and rs4680 polymorphisms study 80
A meta-analysis of biomarkers related to oxidative stress and nitric oxide pathway in migraine 79
Association between migraine and ACE gene (insertion/deletion) polymorphism: the BioBIM study 76
Clinical features, disease progresson and use of healthcare resoiurces in a large sample of 866 patients from 24 headaches centers: a real-life perspective from the italian chronic migraiNE (IRON) project 75
Hypertension as a risk factor for migraine chronification 66
Amitriptyline is effective in chronic but not in episodic tension-type headache: Pathogenetic implications 64
An open study with reversible MAO-A inhibitors in complicated Parkinson's disease 62
Acupuncture in cluster headache: Four cases and review of the literature 61
Unilateral cranial autonomic symptoms in migraine 60
Restless legs syndrome is not associated with migraine with aura: a clinical study 59
Association between migraine and sod1 and sod2 genes polymorphisms: the biobim study 59
Erenumab in the prevention of high-frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real-life study 59
Migraine as a Cortical Brain Disorder 59
Acute pathological laughter induced by sumatriptan 58
A mechanism-based classification of pain in multiple sclerosis 57
Ketogenic diet in migraine: rationale, findings and perspectives 56
Late motor recovery is influenced by muscle tone changes after stroke 56
Migraine and Tourette syndrome 56
Pharmacotherapy for acute migraines in children and adolescents 56
Polymorphism at codon 129 or codon 219 of PRNP and clinical heterogeneity in a previously unreported family with Gerstmann-Straussler-Scheinker disease (PrP-P102L mutation) 55
Reduced density of dopamine D2-like receptors on peripheral blood lymphocytes in Alzheimer's disease 55
Early (<= 1-h) vs. late (> 1-h) administration of frovatriptan plus dexketoprofen combination vs. frovatriptan monotherapy in the acute treatment of migraine attacks with or without aura: a post hoc analysis of a double-blind, randomized, parallel group study 54
Locking down the CGRP pathway during the COVID-19 pandemic lockdown: the PandeMig study 54
Prolonged muscular flaccidity after stroke morphological and functional brain alterations 53
NON-INVASIVE VAGUS NERVE STIMULATION (NVNS) FOR THE ACUTE TREATMENT OF MIGRAINE WITHOUT AURA IN ADOLESCENTS: PRELIMINARY CLINICAL EXPERIENCE 53
Association of 24-h productivity with 2-h pain-free rates following administration of a fast disintegrating/rapid release formulation of sumatriptan 53
Machine learning approach to predict medication overuse in migraine patients 53
Dopaminergic symptoms in migraine: A cross-sectional study on 1148 consecutive headache center-based patients 53
Dopamine hypersensitivity in migraine: Role of the apomorphine test 52
Tardive dyskinesias in the elderly 52
Prolonged muscular flaccidity: frequency and association with unilateral spatial neglect after stroke 52
Circulating Biomarkers in Migraine: New Opportunities for Precision Medicine 52
The evaluation of difficulties with work-related activities caused by migraine: towards a specific questionnaire 52
The role of anti-CGRP antibodies in the pathophysiology of primary headaches 51
Dopamine and migraine: Does Parkinson's disease modify migraine course? 51
Differences in short-term primary motor cortex plasticity as assessed by repetitive transcranial magnetic stimulation in migraine with and without aura 51
Treatment of tension-type headache: from old myths to modern concepts 51
Onabotulinum toxin A in the treatment of chronic migraine: patient selection and special considerations 51
Rizatriptan in migraineurs with unilateral cranial autonomic symptoms: a double-blind trial 50
Migraine patients show an increased density of dopamine D3 and D4 receptors on lymphocytes 50
Cluster headache: management of acute attacks before triptans 50
Excessive daytime somnolence in Parkinson's disease. Follow-up after 1 year of treatment 49
BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study 49
Migraine and movement disorders 49
Prolonged muscular flaccidity in stroke patients is associated with crossed cerebellar diaschisis 49
Erenumab during pregnancy: a case report in a patient with chronic migraine 49
Efficacy of early vs. late use of frovatriptan combined with dexketoprofen vs. frovatriptan alone in the acute treatment of migraine attacks with or without aura 48
Dopamine and migraine: does Parkinson's disease modify the course of migraine? 48
Donepezil in the treatment of progressive supranuclear palsy 48
DOPAMINE BETA HYDROXYLASE (DBH) 19BP INSERTION/DEL POLYMORPHISM INFLUENCES MEDICATION OVERUSE HEADACHE 48
A proposal for a national registry on chronic migraines 48
Tension type headache: a neuropsychological and neurophysiological study 48
Cerebral Transverse Sinus Morphology As Detected by MR Venography in Patients With Chronic Migraine 48
Impact of the International Headache Society criteria on the use of neuroimaging for headache diagnosis in a headache clinic 48
Real-world insights on the management of migraine patients: an Italian nationwide study 48
Pramipexole in Parkinson's disease. A short-term study using the combined levodopa-dopamine agonist test 47
Increased expression of dopamine receptors on lymphocytes in Parkinson's disease 47
Association between Migraine and Progesterone Receptor Gene PROGINS Polymorphism: the BioBIM study 46
Efficacy and Safety of Frovatriptan plus Dexketoprofen in Menstrual Related Migraine (MRM) 46
Shortened cortical silent period in facial muscles of patients with migraine 45
Comparison of frovatriptan plus dexketoprofen (25mg or 37.5 mg) with frovatriptan alone in the treatment of migraine attacks with or without aura: A randomized study 45
Migraine and the extrapyramidal system 45
Case-control genetic association studies in migraine: a 7-year experience at the Interinstitutional Multidisciplinary Biobank (BioBIM) of IRCCS San Raffaele Pisana 45
Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial 45
Drugs targeting nitric oxide synthase for migraine treatment 44
Non-invasive vagus nerve stimulation (nVNS) as symptomatic treatment of migraine in young patients: a preliminary safety study 44
Future trends in drugs for migraine prophylaxis 44
Dopaminergic symptoms in migraine: a case series on 446 consecutive patients 43
Establishment of a biorepository for migraine research: the experience of Interinstitutional Multidisciplinary BioBank (BioBIM) 43
Migraine attack delays gastric emptying: an ultrasonographic study 43
Trigeminal sensory pathway function in patients with SUNCT 43
Chronic migraine: treatability, refractoriness, pseudo-refractoriness 43
Effects of a fast disintegrating/rapid release oral formulation of sumatriptan on functional ability in patients with migraine 42
Prevalence and Time Course of Post-Stroke Pain: A Multicenter Prospective Hospital-Based Study 42
Open-label Pilot Study of Non-invasive Vagus Nerve Stimulation for the Prevention of Menstrual Migraine and Menstrually Related Migraine 42
Look beyond COMT genotype for cathecolamines derangement in migraine: the biobim rs4818 and rs4680 polymorphisms study 41
Creutzfeldt-Jakob disease and related disorders: Etiopathogenetic aspects 41
CEP Cortelli Corrigendum for 515342 (vol 34, pg 434, 2014) 41
Use of dopamine agonists in aged patients with Parkinson's disease 41
Cocaine and headache: a 2-year follow-up study in chronic cocaine users and literature review 41
Impairment of trigeminal sensory pathways in cluster headache 41
Non-invasive vagus nerve stimulation for acute treatment of high-frequency and chronic migraine: an open-label study 41
Unilateral Cranial Autonomic Symptoms in Migraine: A Retrospective Case Series on 757 Patients 41
HEADACHE FREQUENCY AND CHARACTERISTICS IN CHRONIC COCAINE USERS: A CROSS SECTIONAL STUDY 40
Non-invasive Vagus Nerve Stimulation (nVNS) as mini-prophylaxis for menstrual/menstrually related migraine: an open-label study 40
Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial 40
Clinical features, disease progression, and use of healthcare resources in a large sample of 866 patients from 24 headache centers: A real-life perspective from the Italian chROnic migraiNe (IRON) project 40
Headache in chronic cocaine users: A cross-sectional study 39
The role of dopamine in migraine 39
Biomarkers in Migraine Headache: Prognostic and Therapeutic Implications 39
Increased density of dopamine D-5 receptor in peripheral blood lymphocytes of migraineurs: A masker for migraine? 38
Rational for using SSRI (selective serotonin uptake inhibitors) in migraine prophylaxis 38
Totale 5.561
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.028
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.028
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.342 0 0 0 0 49 78 58 35 47 73 940 62
2021/20221.377 18 419 425 6 2 0 103 162 16 200 11 15
2022/2023468 319 8 4 18 16 5 12 16 16 26 22 6
2023/2024387 5 2 9 46 14 52 1 27 0 85 3 143
2024/20251.519 81 221 128 52 86 257 111 107 176 22 39 239
2025/20261.662 259 356 662 381 4 0 0 0 0 0 0 0
Totale 7.522